CLINICAL TRIAL #1
EnLyte has been shown to be safe and effective in patients with MDD and MTHFR SNP in this 8-week monotherapy clinical study
CLINICAL TRIAL #2
A clinical study conducted at Massachusetts General Hospital in conjunction with Harvard University showed that in addition to preventing neural tube defects, EnBrace HR is able to finally give women with depression an option to safely forego antidepressant medication while they're trying to conceive, during pregnancy, and postpartum.
EnLyte combines all of the coenzymes, cofactors and omegas needed within the Methylation Cycles to treat the biochemical root cause of depression
FOLATE AND DEPRESSION META-ANALYSIS
The association of folate and depression: A meta-analysis
Pediatric depression remains a treatment challenge, not only because of its increasing prevalence over the past year, but the "black box warning," which elaborates the possibility of suicidal thoughts or behaviors associated with antidepressant use in younger patients.
Published in Clinical Psychiatry
Dr. Andrew Farah and
Dr. Gauri Madan
What is the MTHFR Gene?
Written By Dr. Bruce Kehr
About Potomac Psychiatry:
Bruce Alan Kehr, M.D. is the Founder and President of Potomac Psychiatry. He has been named a Washingtonian Magazine “Top Doctor” annually for many years. In 2019 he was the only adult psychiatrist named “Top Doctor” by Bethesda Magazine. He received its "Top Doctor" award again in 2021. Dr. Kehr is also a Castle Connolly Top Doctor five years running, since 2016. In 2021, Under Dr. Kehr's leadership, Potomac Psychiatry was awarded "Best Comprehensive Psychiatric Care Services - Northeast USA" by Global Health & Pharma.
“I have a chemical imbalance…” A statement I have heard countless times throughout my career. No one can blame the patient for saying it: when they see a psychiatrist, even after a first visit, the patient usually leaves with a prescribed chemical, designed to cross the blood-brain barrier.
Written by Dr. Andrew Farah